Kura Oncology (KURA) Tops Q4 EPS by 35c

Kura Oncology (NASDAQ: KURA) reported Q4 EPS of ($0.22), $0.35 better than the analyst estimate of ($0.57).

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• Aggreko files for proposed IPO
• Supreme Court lifts decision that blocked in 23 states and Washington, D.C. Trump's order restricting mail-in ballots
• Co-Diagnostics (CODX) files for 3.4M share offering by selling stockholders